openPR Logo

Press Releases from Roots Analysis (285 total)

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract man …

Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers Roots Analysis is

Peptide Therapeutics: Contract API manufacturing market is estimated to be worth …

Given the growing demand for peptide drugs and the complexities associated with their development and production, relying on the superior technical expertise and experience of

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract man …

Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers Roots Analysis is

The oligonucleotide synthesis, modification and purification services market is …

The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of

The fragment-based drug discovery market is estimated to be worth around USD 1.6 …

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering

The contract manufacturing market for Pharmaceuticals in China is estimated to b …

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business

The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, …

Advances in the medical device industry have led to a substantial increase in developmental complexity, clinical trial conduct, and stringency of regulatory review, causing sponsors

The continuous manufacturing market is estimated to be worth around USD 2 billio …

Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more

The global preventive vaccines market is projected to be worth USD 94 billion by …

Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still

The Chinese biopharmaceutical contract manufacturing market is estimated to be w …

The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several

The global handheld ultrasound imaging devices market is projected to be over US …

The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major

The High Energy / Hazardous Chemistry-based API manufacturing services market is …

Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a wide range of benefits over

The contract manufacturing market for live biotherapeutics and microbiome produc …

With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to

The opportunity for AR / VR based digital marketing service providers in healthc …

Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies

Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 bil …

A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental

The nuclear medicine and radiopharmaceutical manufacturing market is estimated t …

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies

The drug repurposing service providers market is estimated to be worth USD 1.2 b …

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities

The global digital therapeutics market is projected to be worth over USD 8.86 bi …

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking

The human factors engineering and usability testing services market for medical …

Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize

The human factors engineering and usability testing services market for medical …

Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize

The microbial contract biomanufacturing market is projected to be worth USD 9.3 …

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2 …

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by …

Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm

In silico drug discovery services market is likely to be worth USD 124 million b …

Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed novel tools, which

The microbial contract biomanufacturing market is projected to be worth USD 9.3 …

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities

The single-cell sequencing services and technologies market is projected to be w …

The advantages of single-cell analysis, which include high specificity and sensitivity, have garnered a lot of attention among medical researchers; the technique is anticipated to

The global digital therapeutics market is projected to be worth over USD 8.9 bil …

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking

The microbial contract biomanufacturing market is projected to be worth USD 9.3 …

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities

The contract regulatory affairs-management services market for medical devices i …

In order to reduce risk of device recalls and expedite time to market, medical device developers rely on contract service providers for regulatory submissions and

The contract manufacturing services market for stem cells is expected to be wort …

Roots Analysis has announced the addition of the “Stem Cell Contract Manufacturing Market, 2019-2030” report to its list of offerings. Owing to a highly regulated

Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competit …

Roots Analysis has announced the addition of “Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights” report to its list of offerings. Ishita

Real World Evidence: Market Landscape and Competitive Insights, 2018-2030

Roots Analysis has announced the addition of “Real World Evidence: Market Landscape and Competitive Insights, 2018-2030” report to its list of offerings. Prabhjot Kaur, the

Smart Wearables: The Future of Personalized Healthcare

Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis

CELL LINE DEVELOPMENT SERVICES MARKET TO WITNESS STEADY GROWTH IN THE COMING DEC …

Roots Analysis has announced the addition of “Cell Line Development Services Market, 2017-2027” report to its list of offerings. The report features an extensive study

Gene Therapy Market to be Worth over USD 10 billion by 2025, predicts Roots Anal …

Roots Analysis has announced the addition of “Gene Therapy Market, 2015-2025” report to their offering. The market currently has only five approved therapies; of these,

Go To Page:    1 2 3 4 5